December 11, 2013
Ono Pharmaceutical said on December 9 that it has submitted a clinical trial application for a PI study on ONO-7268MX2, a peptide-cocktail vaccine for hepatocellular carcinoma (HCC) licensed from Japanese startup OncoTherapy Science. ONO-7268MX2 contains multiple epitope peptides derived from...read more